Rate of T alleles and TT genotype at MTHFR 677C->T locus or C alleles and CC genotype at MTHFR 1298A->C locus among healthy subjects in Turkey: Impact on homocysteine and folic acid status and reference intervals

Cell Biochemistry and Function

Volumn 27, Issue 8, 2009, Pages 568-577

  Ozarda, Yesim ^a   Sucu, Derya Kaynak ^b   Hizli, Banu ^a   Aslan, Diler ^c  

^a ULUDAG UNIVERSITY   (Turkey)

^b BALIKESIR UNIVERSITY   (Turkey)

^c PAMUKKALE UNIVERSITY   (Turkey)

Author keywords

Folate; Homocysteine; MTHFR; Mutations; Reference intervals; Turkey; Vitamin B12

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ALANINE; CYANOCOBALAMIN; CYSTEINE; FOLIC ACID; HOMOCYSTEINE; METHIONINE; THREONINE;

ADULT; ALLELE; AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; FEMALE; FOLIC ACID BLOOD LEVEL; GENE LOCUS; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN EXPERIMENT; MALE; METHYLATION; MUTATION RATE; NORMAL HUMAN; PRIORITY JOURNAL; REFERENCE VALUE; TURKEY (REPUBLIC); VITAMIN BLOOD LEVEL; VITAMIN METABOLISM;

ADOLESCENT; ADULT; ALLELES; FEMALE; FOLIC ACID; GENOTYPE; HEALTH STATUS; HOMOCYSTEINE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POINT MUTATION; TURKEY; VITAMIN B 12; YOUNG ADULT;

EID: 71949087027     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1610     Document Type: Article

References (71)

1. Bailey LB, Gregory JF 3rd. Polymorphism of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr 1999; 129: 919-922.
2. Bailey LB, Gregory JF 3rd. Folate metabolism and requirements. J Nutr 1999; 129: 779-782.
3. Finkelstein JD. Metionine metabolism in mammals. J Nutr Biochem 1990; 1: 228-237.
4. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, Matthews RG, Rozen R. Human methylenetetrahyrofolate reducatase: isolation of cDNA mapping and mutation identification. Nat Genet 1994; 7: 551.
5. Goyette P, Pai A, Milos R, Frosst P, Tran P, Chen Z, Chan M, Rozen R. Gene structure of human and mouse methylenetetrahdyrofolate reductase (MTHFR). Mamm Genome 1998; 13: 652-656. (Pubitemid 28355328)
6. Frostt P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers CJ, den Heijer M, Kluijmans LA, van den Heuvel LP. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
7. Chango A, Boisson F, Barbe F, Quilliot D, Droesch S, Pfister M, Filon- Emery N, Lambert D, Fremont S, Rosenblatt DS, Nicolas JP. The effect of 677C->T and 1298 A->C mutations on plasma homocysteine and 5,10-methylenetetrahydrofolate reductase activity in healthy subjects. Br J Nutr 2000; 83: 593-596. (Pubitemid 30392098)
8. van der Put NM, Gabreels F, Stevens EM, Smeitink JA, Trijbels FJ, Eskes TK, van den Heuvel LP, Blom HJ. A second common mutation in the methylenetetrahdyrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet1998;62: 1044-1051.
9. Weisberg I, Tran P, Christensen B, Sibani S, Rozen R. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998; 64: 169-172. (Pubitemid 28453294)
10. Weisberg IS, Jacques PF, Selhup J, Bostom AG, Chen Z, Curtis Ellison R, Eckfeldt JH, Rozen Rl. The 1298A->C polymorphism in methlenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 2001; 156: 409-415. (Pubitemid 32522922)
11. Friedman G, Goldschmidt N, Friedlander Y, Ben-Yehuda A, Selhub J, Babaey S, Mendel M, Kidron M, Bar-On H. A common mutation A1298C in human methylenetetrahydrofolate reductase gene: association with plasma total homocysteine and folate concentrations. J Nutr 1999; 129: 1656-1661. (Pubitemid 29406617)
12. de Bree A, Verschuren WM, Bjorke-Monsen AL, van der Put NM, Heil SG, Trijbels FJ, Blom HJ. Effect of the methylenetetrahydrofolate reductase 677C->T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. Am J Clin Nutr 2003; 77: 687-693.
13. Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M. DACH-LIGA homocystein (german, austrian and swiss homocystein society): consencus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 2003; 41: 1392-1403. (Pubitemid 37493551)
14. Klerk M, Verhoef P, Clarke R, Blom HJ, Kok FJ, Schouten EG. MTHFR Studies Collaboration Group. MTHFR 677C->T polymorphism and risk of coronary heart disease; a meta-analysis. JAMA 2002; 288: 2023-2031.
15. Kolling K, Ndrepepa G, Koch W, Braun S, Mehilli J, Schomig A, Kastrati A. Methylenetetrahydrofolate reductase gene C677T and A1298C polymorphisms, plasma homocysteine, folate and vitamin B12 levels and the extent of coronary artery disease. Am J Cardiol 2004; 93: 1201-1206. (Pubitemid 38595670)
16. Hanson NQ, Aras O, Yang F, Tsai MY. C677T and A1298C polymorphisms of the methylenetetrahydrofolate reductase gene: incidence and effect of combined genotypes on plasma fasting and post-methionine load homocysteine in vascular disease. Clin Chem 2001; 47: 661-666. (Pubitemid 32275808)
17. Zee RY, Mora S, Cheng S, Erlich HA, Lindpaintner K, Rifai N, Buring JE, Ridker PM. Homocysteine, 5,10-metylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women. Clin Chem 2007; 53: 845-851.
18. Girelli D, Martinelli N, Pizzolo F, Friso S, Olivieri O, Stranieri C, Trabetti E, Faccini G, Tinazzi E, Pignatti PF, Corrocher R. The interaction between MTHFR 677C->T genotype and folate status is a determinant of coronary atherosclerosis risk. J Nutr 2003; 133: 1281-1285. (Pubitemid 36548695)
19. Chen J, Giovannucci EL, Hunter DJ. MTHFR polymorphism, methylreplete diet and the risk of colorectal carsinoma and adenoma among U.S. men and women: an example of gene-environment interactions in colorectal tumorigenesis. J Nutr 1999; 129: 560S-564S. (Pubitemid 29069669)
20. Nishiyama M, Kato Y, Hashimoto M, Yukawa S, Omori K. Apolipoprotein E, metylenetetrahdyrofolate reductase mutation (MTHFR) and the risk of senil dementia- an epidemiological study using the polymerase chain reaction (PCR) method. J Epidemiol 2000; 10: 163-172.
21. Gilbody S, Lewis S, Lightfoot T. Methylenetetrafolate reductase (MTHFR) genetic polimorphisms and psychiatric disorders: a HuGE Review. Am J Epidemiol 2007; 165: 1-13. (Pubitemid 46026203)
22. van der Put NM, van Straaten HW, Trijbels FJ, Blom HJ. Folate, homocysteine and neural tube defects: an overview. Exp Biol Med 2001; 226: 234-270.
23. van Beynum IM, den Heijer M, Blom HJ, Kapusta L. The MTHFR 677C->T polymorphism and the risk of congenital heart defects: a literature review and meta-analysis. QJM 2007; 100: 743-753.
24. Ceriotti F, Hinzmann R, Panteghini M. Reference intervals: the way forward. Ann Clin Biochem 2009; 46: 8-17.
25. Horn PS, Pesce AJ. Reference intervals: an update. Clin Chim Acta 2003; 334: 5-23.
26. Solberg HE. International Federation of Clinical Chemistry (IFCC). Approved recommendation (1987) on the theory of reference values. Part 1. The concept of individuals for the production of reference values. Clin Chim Acta 1987; 167: 111-118.
27. J Clin Chem Clin Biochem 1987; 25: 337-342.
28. Annals of Biol Clin 1987; 45: 237-241.
29. Labmedica 1987; 4: 27-31.
30. PetitClerc C, Solberg HE. International Federation of Clinical Chemistry (IFCC). Approved recommendation (1987) on the theory of reference values. Part 2. Selection of individuals for the production of reference values. J Clin Chem Clin Biochem 1987; 25: 639-644.
31. Clin Chim Acta 1987; 170: S3-12.
32. Solberg HE, PetitClerc C. International Federation of Clinical Chemistry (IFCC). Approved recommendation (1988) on the theory of reference values. Part 3. Preparation of individuals and collection of specimens for the production of reference values. J Clin Chem Clin Biochem 1988; 26: 593-598.
33. Clin Chim Acta 1988; 177: S1-12.
34. Solberg HE, Stamm D. International Federation of Clinical Chemistry (IFCC). Approved recommendation (1991) on the theory of reference values. Part 4. Control of anaytical variation in the production, transfer and application of reference values. Eur J Clin Chem Clin Biochem 1991; 29: 531-535.
35. Clin Chim Acta 1991; 202: S5-12.
36. Solberg HE. International Federation of Clinical Chemistry (IFCC). Approved recommendation (1987) on the theory of reference values: Part 5. Statistical treatment of collected reference values: determination of reference limits. J Clin Chem Clin Biochem 1987; 25: 645-656.
37. Clin Chim Acta 1987; 170: S13-32.
38. Dybkaer R, Solberg HE. International Federation of Clinical Chemistry (IFCC). Approved recommendation (1987) on the theory of reference values: Part 6. Presentation of observed values related to reference values. J Clin Chem Clin Biochem 1987; 25: 657-662.
39. Clin Chim Acta 1987; 170: S33-42.
40. Labmedica 1988; 5: 27-30.
41. Clinical and Laboratory Standarts Institute. How to Define and Determine Reference Intervals in the Clinical Laboratory; Approved Guideline (CLSI document C28-A2), 2 nd edition. Clinical and Laboratory Standarts Institute: Wayne, PA, USA, 2000.
42. Ilcol YO, Aslan D. Determining reference values of blood chemistry profile in healthy subjects in Bursa. Turk J Biochem 2004; 29: 183-192. http://www.turkbiochem.com.
43. Ilcol YO, Aslan D. Use of total patient data for indirect estimation of reference intervals for 40 clinical chemical analytes in Turkey. Clin Chem Lab Med 2006; 44: 867-876. (Pubitemid 43911562)
44. Sazci A, Ergul E, Kaya G, Kara I. Genotype and allele frequencies of the polymorphic methylenetetrahydrofolate reductase gene in Turkey. Cell Biochem Funct 2005; 23: 51-54. (Pubitemid 40065173)
45. Baytan B, Gunes Meral A, Ilcol YO, Gunay U. The prevalence of factor V Leiden (1691G-A) and metylene tetrahydrofolatereductase C677T mutations in healthy newborns in Bursa, Turkey. Turk J Hematol 2007; 4: 90-92. (Pubitemid 47243927)
46. Rady PL, Tyring SK, Hudnall SD, Vargas T, Kellner LH, Nitowsky H, Matalon RK. Methylenetetrahydrofolate reductase (MTHFR): The incidence of mutations C677T and A1298C in the Ashkenazi Jewish population. Am J Med Genet 1999; 86: 380-384. (Pubitemid 29461501)
47. Stegmann K, Ziegler A, Nqo ET, Kohlschmidt N, Schoter B, Ermert A, Koch MC. Linkage disequilibrium of MTHFR genotypes 677C/T-1298A/C in the German population and association studies in probands with neural tube defects (NTD). Am J Med Genet 1999; 87: 23-29. (Pubitemid 29522057)
48. Russo GT, Friso S, Jacques PF, Rogers G, Cucinotta D, Wilson PW, Ordovas JM, Rosenburg IH, Selhub J. Framingham Offspring Study Cohort. Age and gender affect the relation between metylenetetrahydrofolate reductase C677T genotype and fasting plasma homocysteine concentrations in the Framingham Offspring study cohort. J Nutr 2003; 133: 3416-3421. (Pubitemid 37409467)
49. Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW, Wright JD, Johnson CL. Serum total homocysteine concentrations in the third national health and nutrition examination survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med 1999; 131: 331-339.
50. Bailey LB, Duhaney RL, Maneval DR, Kauwell GP, Ouinlivan EP, Davis SR, Cuadras A, Hudson AD, Gregory JF 3rd. Vitamin B-12 status is inversely associated with plasma homocystein in young women with C677T and/or A1298C methylenetetrahydrofolate reductase polymorphisms. J Nutr 2002; 132: 1872-1878. (Pubitemid 34742870)
51. Pepe G, Camacho Vanegas O, Giusti B, Brunelli T, Marcucci R, Attanasio M, Rickard O, De Stefano GF, Prisco D, Gensini GF, Abbate R. Heterogeneity in world distribution of the thermolabile C677T mutation in 5,10- methlenetetrahydrofolate reductase. Am J Human Genet 1998; 63: 917-920. (Pubitemid 30422697)
52. Gueant-Rodriguez R-M, Gueant JL, Debard R, Thirion S, Hong LX, Bronowicki J-P, Namour F, Chabi NW, Sanni A, Anello G, Bosco P, Romano C, Amouzou E, Arrietta F, Arrietta HR, Sanchez BE, Romano A, Herbeth B, Guilland JC, Mutchinick OM. Prevalence of methylenetetrahydrofolate reductase 677Tand 1298C alleles and folate status: a comparative study in Mexican, West African, and European populations. Am J Clin Nutr 2006; 83: 701-707. (Pubitemid 44699219)
53. Schneider JA, Rees DC, Liu YT, Clegg JB. Woldwide distribution of a common methylenetetrahdyrofolate reductase mutation. Am J Human Genet 1998; 62: 1258-1260. (Pubitemid 28199029)
54. Mao R, Fan Y, Chen F, Sun D, Bai J, Fu S. Methylenetetrahydrofolate reducates gene polymorphisims in 13 Chinese ethnic populations. Cell Biochem Funct 2008; 26: 352-358. (Pubitemid 351613177)
55. Dierkes J, Jeckel A, Ambroch A, Westphal S, Luley C, Boeing H. Factors explaining the difference of total homocysteine between men and women in the European Investigation Into Cancer and Nutrition Potsdam study. Metabolism 2001; 50: 640-645. (Pubitemid 32551815)
56. Morris MS, Jacques PF, Selhup J, Rosenberg IH. Total homocysteine and estrogen status indicators in the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2000; 152: 140-148. (Pubitemid 30463662)
57. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM. Plasma homocysteine as a risk factor for vascular disease. The Eurepean Concerted Action Project. JAMA 1997; 277: 1775-1781.
58. Castanon MM, Lauricella AM, Kordich L, Quintana I. Plasma homocysteine cutoff values for venous thrombosis. Clin Chem Lab Med 2007; 45: 232-236. (Pubitemid 46294689)
59. Mahley RW, Palaoǧlu KE, Atak Z, Dawson-Pepin J, Langlois AM, Cheung V, Onat H, Fulks P, Mahley LL, Vakar F. Turkish heart study: Lipids, lipoproteins, and apolipoproteins. J Lipid Res 1995; 36: 839-859.
60. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 2001; 156: 1-10. (Pubitemid 32429589)
61. Tokgözoǧlu SL, Alikasifoǧlu M, Unsal I, Atalar E, Aytemir K, Ozer N, Ovünç K, Usal O, Kes S, Tunçbilek E. Metylene tetrahydrofolate reductase genotype and the risk and extent of coronary artery disease in population with low plasma folate. Heart 1999; 81: 518-522. (Pubitemid 29234313)
62. Gulec S, Aras O, Akar E, Tutar E, Omurlu K, Avci F, Dinçer I, Akar N, Oral D. Metylenetetrahydrofolate reductase gene polymorphism and risk of premature myocardial infarction. Clin Cardiol 2001; 24: 281-284.
63. Sipahi E, Taskin G, Kumbasar D, Halloran M, Yildirimkaya M, Nadirler F, Yildirir A, Berkalp B, Laleli Y. Hyperhomocysteinaemia and coronary artery disease in the Turkish population. Acta Cardiol 2002; 57: 415-420. (Pubitemid 36025604)
64. Akar N, Akar E, Akcay R, Avcu F, Yalcin A, Cin S. Effect of methylenetetrahydrofolate reductase 677 C-T, 1298 A-C, and 1317 T-C on factor V 1691 mutation in Turkish deep vein thrombosis patients. Thrombosis Res 2000; 97: 163-167. (Pubitemid 30055281)
65. Dikmen M, Ozbabalik D, Gunes HV, Degirmenci I, Bal C, Ozdemir G, Basaran . Acute stroke in relation to homocystein and methylenetetrahydrofolate reductase gene polymorphisms. Acta Neurol Scand 2006; 113: 307-314.
66. D'Angelo A, Coppola A, Madonna P, Fermo I, Pagano A, Mazzola G, Galli L, Cerbone AM. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case control study of patients with early-onset thrombotic evets. Thromb Haemost 2000; 83: 563-570.
67. Vaughn JD, Bailey LB, Shelnutt KP, Dunwoody KM, Maneval DR, Davis SR, Qunlivan EP, Gregory JF 3rd, Theriaque DW, Kauwell GP. Methionine synthase reductase 66A->G polymorpism is asociated with increased plasma homocystein concentrations when combined with the homozygous methylenetetrahydrofolate reductase 677C->T variant. J Nutr 2004; 134: 2985-2990.
68. Brouwer DAJ, Welten HTME, Reijngoud DJ, van Doormaal JJ, Muskiet FA. Plasma folic acid cutoff value, derived from its realtionship with homocyst(e)ine. Clin Chem 1998; 44: 1545-1550.
69. Onat A, Hergenç G, Küçükdurmaz Z, Can G, Ayhan E, Bulur S. Serum folate is associated with coronary heart disease independently of homocystein in Turkish men. Clin Nutr 2008; 27: 732-739.
70. Dhonukshe-Rutten RA, de Vries JH, de Bree A, van der Put N, van Staveren WA, de Groot LC. Dietary intake and status of folate and vit B12 and their asssociation with homocysteine and cardiovascular disease in European populations. Eur J Clin Nutr 2009; 63: 18-30.
71. Tuncbilek E, Boduroglu K, Alikasifoglu M. Neural tube defects in Turkey: prevalence, distribution and risk factors. Turk J Pediatr 1999; 41: 299-305.